Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)

Company Overview - Zoetis Inc. has emerged as the leading pharmaceutical company in animal health since its spin-off from Pfizer in 2012 [1] - Approximately two-thirds of Zoetis's revenue is derived from its animal health products [1] Investment Insights - The company represents a significant opportunity for investors looking for stable growth in the pharmaceutical sector focused on animal health [1]